-+ 0.00%
-+ 0.00%
-+ 0.00%

OSE IMMUNOTHERAPEUTICS SA - REGAINS CONTROL OF EARLY-STAGE DEVELOPMENT OF ABBV-230, UNDER THE REVISED AGREEMENT

Reuters·12/08/2025 06:30:03

Please log in to view news